HR-4866 : Still Just a Bill

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019

This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

Action Timeline

Action DateTypeTextSource
2020-09-22IntroReferralReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Senate
2020-09-21FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2020-09-21FloorOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4616-4617)House floor actions
2020-09-21FloorDEBATE - The House proceeded with forty minutes of debate on H.R. 4866.House floor actions
2020-09-21FloorConsidered under suspension of the rules. (consideration: CR H4616-4618)House floor actions
2020-09-21FloorMrs. Dingell moved to suspend the rules and pass the bill, as amended.House floor actions
2020-09-17CalendarsPlaced on the Union Calendar, Calendar No. 413.House floor actions
2020-09-17CommitteeReported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-513.House floor actions
2020-07-15CommitteeOrdered to be Reported (Amended) by Voice Vote.House committee actions
2020-07-15CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2020-03-11CommitteeForwarded by Subcommittee to Full Committee (Amended) by Voice Vote .House committee actions
2020-03-11CommitteeSubcommittee Consideration and Mark-up Session Held.House committee actions
2019-10-29CommitteeReferred to the Subcommittee on Health.House committee actions
2019-10-28IntroReferralReferred to the House Committee on Energy and Commerce.House floor actions
2019-10-28IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Advanced technology and technological innovations
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Health programs administration and funding
  • Health technology, devices, supplies
  • Higher education
  • Manufacturing
  • Prescription drugs
  • Product development and innovation
  • Research administration and funding
  • Research and development

Related Bills

See Related Bills